← Back to Search

Behavioural Intervention

Evening Screen Time for Sleep Issues in Kids

N/A
Recruiting
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 9-13 and day 16-20
Awards & highlights

Study Summary

This trial examines effects of evening tablet use on kids' sleep, behavior, and cognitive abilities.

Who is the study for?
This study is for preschool-aged children (4 to just under 5 years old) and their parents in the Greater Houston area. Parents must be primary caregivers, comfortable with English, and have a child who uses or has access to an Android OS ≥5.0 or Apple iOS ≥14.0 tablet.Check my eligibility
What is being tested?
The study examines how using tablets in the evening affects young children's sleep patterns and behavior compared to not using screen media at all. It looks into when kids fall asleep, how long they sleep, and their ability to control impulses.See study design
What are the potential side effects?
Since this trial involves technology use rather than medication, traditional side effects are not applicable. However, potential impacts may include changes in sleep quality or duration as well as alterations in mood or behavior.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 9-13 and day 16-20
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 9-13 and day 16-20 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Dim light Melatonin Onset Phase
Secondary outcome measures
Change in Average Sleep duration
Change in Inhibitory Control-Day/Night
Change in Inhibitory Control-Grass/Snow
+3 more
Other outcome measures
Ambient Light Exposure
Average daily duration of Tablet use (excluding the experimental exposures)
Children's Sleep Habits Questionnaire
+4 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Group B: 1 hour of tablet use 2 hours before bedExperimental Treatment1 Intervention
During week 1, children will maintain a sleep schedule within 30 minutes +/- of their habitual bedtime. This bedtime will be maintained throughout the 3 weeks of the study except on nights when dim light melatonin onset is assessed in the lab. During week 2, participants will be asked to reframe from screen use in the 3 hours before bedtime for 6 evenings. During week 3, participants will be exposed to 1 hour of tablet use (Standard bright setting), 2 hours before bedtime (and no screen use in the hour before bed) for 6 evenings.
Group II: Group A: 1 hour of tablet use in the hour before bedExperimental Treatment1 Intervention
During week 1, children will maintain a sleep schedule within 30 minutes +/- of their habitual bedtime. This bedtime will be maintained throughout the 3 weeks of the study except on nights when dim light melatonin onset is assessed in the lab. During week 2, participants will be asked to reframe from screen use in the 3 hours before bed time for 6 evenings. During week 3, participants will be exposed to 1 hour of tablet use (Standard bright setting), 1 hour before bedtime for 6 evenings.
Group III: Control ConditionActive Control1 Intervention
During week 1, children will maintain a sleep schedule within 30 minutes +/- of their habitual bedtime. This bedtime will be maintained throughout the 3 weeks of the study except on nights when dim light melatonin onset is assessed in the lab. During week 2, participants will engage no screen use for the 3 hours before bedtime for 6 evenings. During week 3, participants will be asked to engage in no screen use in the 3 hours before bedtime for 6 evenings.

Find a Location

Who is running the clinical trial?

Northern Illinois UniversityOTHER
8 Previous Clinical Trials
760 Total Patients Enrolled
William Marsh Rice UniversityOTHER
45 Previous Clinical Trials
27,763 Total Patients Enrolled
Baylor College of MedicineLead Sponsor
1,001 Previous Clinical Trials
6,002,090 Total Patients Enrolled
2 Trials studying Sleep
310 Patients Enrolled for Sleep

Media Library

Timed evening technology and digital media use (tablet use) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05820555 — N/A
Sleep Research Study Groups: Group A: 1 hour of tablet use in the hour before bed, Group B: 1 hour of tablet use 2 hours before bed, Control Condition
Sleep Clinical Trial 2023: Timed evening technology and digital media use (tablet use) Highlights & Side Effects. Trial Name: NCT05820555 — N/A
Timed evening technology and digital media use (tablet use) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05820555 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has recruitment for this experiment commenced?

"Clinicaltrials.gov confirms that this research endeavor, which was initially posted on April 24th 2023, is currently seeking participants. The listing has been edited recently on May 5th 2023."

Answered by AI

What is the aggregate count of enrollees in this investigation?

"Affirmative. Clinicaltrials.gov states that this trial has commenced its recruitment phase, having first been posted on April 24th 2023 and last revised five days later. The research team is looking for 90 participants from a single medical centre."

Answered by AI

For what demographic is this clinical trial accepting applicants?

"This clinical trial accepts 90 patients between 4 and 5 years of age. To be eligible, participants must meet the criteria concerning their sleep patterns."

Answered by AI

Does this experiment include older adults in its participant pool?

"This research is open to participants between 4 and 5 years old."

Answered by AI
~60 spots leftby May 2026